76
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Drug holidays: the most frequent type of noncompliance with calcium plus vitamin D supplementation in persistent patients with osteoporosis

, , , , , , & show all
Pages 1771-1779 | Published online: 16 Dec 2015
 

Abstract

Purpose

All current recommendations include calcium and vitamin D (Ca–D) as an integrated part of osteoporosis treatment. The purpose of this pilot study was to analyze compliance with a fixed combination of Ca–D in women persistent with the treatment.

Patients and methods

An observational study was carried out in three osteocenters in the Czech Republic. Women with osteoporosis ≥55 years of age concurrently treated with oral ibandronate were eligible. Compliance was evaluated in a period of 3 months by Medication Event Monitoring System (MEMS), tablet count, and self-report. Nonpersistence was defined as a MEMS-based gap in the use of Ca–D to be 30 days or more.

Results

A total of 73 patients were monitored, of which 49 patients were analyzed (target population). Based on MEMS, mean overall compliance was 71%; good compliance (≥80%) was observed in 59% of the patients. As many as 71% of the patients took drug holidays (≥3 consecutive days without intake); overall compliance of these patients was 59% and was slightly lower on Fridays and weekends. Patients without drug holidays were fully compliant (did not omit individual doses). Compliance differed according to daily time at which the patients mostly used the Ca–D. Afternoon/evening takers showed a mean overall compliance of 82% while morning/night takers only 51% (P=0.049). Based on MEMS, tablet count, and self-report, compliance ≥75% was observed in 59%, 100%, and 87% of the patients, respectively. Outcomes obtained by the three methods were not associated with each other. Undesirable concurrent ingestion of Ca–D and ibandronate was present only twice.

Conclusion

Despite almost perfect self-reported and tablet count-based compliance, MEMS-based compliance was relatively poor. Consecutive supplementation-free days were common; more than two-thirds of the patients took at least one drug holiday. This pilot study showed drug holiday to be the most important type of noncompliance with Ca–D in those who are persistent with the treatment.

Acknowledgments

We are grateful to Dr Bernard Vrijens for consultation on electronically-compiled dosing histories and sharing his profound, wide-ranging experience in medication adherence research. The authors would like to thank the physicians for patient recruitment: Prof Karel Pavelka, MUDr Olga Ruzickova, and MUDr Tomas Hala; further, thanks to Prof Jiri Vlcek for support of the MEMS method, Vera Holkova who assisted in study organization and data collection, and Mgr Michal Urbanek for English editing. The study was supported by Charles University in Prague, project SVV 260 187, and Program MH CZ – DRO (UHHK, 00179906).

Disclosure

The authors report no conflicts of interest in this work.